داروسازی لقمان

دلقما | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: 9,900 2.06

Close Price: 9,720

	2026/07/12 Fiscal Year 2026/03/2012 Month	2025/07/19 Fiscal Year 2025/03/2012 Month	2024/07/21 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	27.59	7.34	8.47
Gross Profit to Sales	31.91	9.29	10.87
Operating Margin	30.78	13.57	14.46
Gross Profit to Sales	36.09	21.76	19.48
Net Profit to Gross Profit	76.43	33.74	43.46
Return on Assets (ROA)	19.6	3.92	4.73
Return on Capital (%)	63.25	12.65	12.37
Return on Equity (ROE)	37.96	7.51	7.57
Working Capital Return	62.38	23.64	26.98
Fixed Asset Return	115.86	16.26	15.75
Loan Benefit Assessment	1.94	1.92	1.6
Current Ratio	1.67	1.36	1.49
Quick Ratio	1.38	1.09	1.19
Liquidity Ratio	0.16	0.1	0.03
Net Working Capital	10,378,314	3,604,745	3,086,761
Current Assets Ratio	0.78	0.63	0.54
Inventory Turnover	87.75	91.32	80.08
Receivables Collection Period	277.98	301.77	242.53
Inventory to Working Capital	0.44	0.74	0.61
Working Capital Turnover	2.26	3.22	3.19
Fixed Asset Turnover	4.2	2.22	1.86
Total Asset Turnover	0.71	0.53	0.56
Debt Ratio	0.48	0.48	0.38
Debt to Equity	0.94	0.92	0.6
Long-Term Debt to Equity	0.03	0.03	0.03
Current Debt to Equity	0.91	0.88	0.58
Equity Ratio	51.62	52.14	62.44
Debt Coverage Ratio	10.54	13.27	19.06

At a Glance